Literature DB >> 22327804

A high molecular weight protein extract of Mastobranchus indicus (Mi-64) having antiarthritic activity in experimental animals.

Mohammed Aftab Alam1, Santosh Kumar Sarkar, Antony Gomes.   

Abstract

Mi-64, a high molecular weight protein (130 kDa), obtained from the tissue homogenate of marine polychaete (Mastobranchus indicus) collected from the Indian Sunderban has antiarthritic activity in experimental animals. The FCA-induced arthritis model was developed in Wistar albino rats to evaluate the antiarthritic effects of Mi-64. After FCA induction, the rats were treated with Mi-64 (0.25 and 0.5 mg kg(-1) body weight) for 10 days. We have determined the paw/ankle swellings, urinary hydroxyproline and glucosamine, serum acid and alkaline phosphatases to assess the antiarthritic activity. The levels of interleukin-1 beta (IL-1β), IL-6, cytokine-induced neutrophil chemoattractant-1 (CINC-1), tumor necrosis factor-alpha (TNF-α), and IL-10 were measured by ELISA. Results showed that Mi-64 significantly reduced paw/ankle swellings and restored the urinary hydroxyproline/glucosamine and serum phosphatases. Mi-64 significantly inhibited the overproduction of IL-1β, IL-6, CINC-1, and TNF-α and augmented IL-10 production. The data suggest that Mi-64 produced significant antiarthritic effects that may be mediated by balancing the pro- and anti-inflammatory cytokines.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22327804     DOI: 10.1007/s10753-012-9432-y

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  50 in total

1.  Glycolipoprotein extract (G-90) from earthworm Eisenia foetida exerts some antioxidative activity.

Authors:  M Grdisa; M Popovic; T Hrzenjak
Journal:  Comp Biochem Physiol A Mol Integr Physiol       Date:  2001-04       Impact factor: 2.320

2.  Fibrinolytic activity of earthworms extract (G-90) on lysis of fibrin clots originated from the venous blood of patients with malignant tumors.

Authors:  T M Hrzenjak; M Popović; L Tiska-Rudman
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

Review 3.  Earthworm immune responses.

Authors:  J Jarosz; Z Gliński
Journal:  Folia Biol (Krakow)       Date:  1997       Impact factor: 0.432

4.  Interleukin 6 knock-out mice are resistant to antigen-induced experimental arthritis.

Authors:  A Boe; M Baiocchi; M Carbonatto; R Papoian; O Serlupi-Crescenzi
Journal:  Cytokine       Date:  1999-12       Impact factor: 3.861

5.  A novel anti-rheumatic drug suppresses tumor necrosis factor-alpha and augments interleukin-10 in adjuvant arthritic rats.

Authors:  M Hisadome; T Fukuda; H Sumichika; T Hanano; K Adachi
Journal:  Eur J Pharmacol       Date:  2000-12-15       Impact factor: 4.432

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 7.  Role of cytokines in rheumatoid arthritis.

Authors:  M Feldmann; F M Brennan; R N Maini
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

8.  Effects of glucosamine administration on patients with rheumatoid arthritis.

Authors:  Hiroshi Nakamura; Kayo Masuko; Kazuo Yudoh; Tomohiro Kato; Toshikazu Kamada; Tohru Kawahara
Journal:  Rheumatol Int       Date:  2006-09-05       Impact factor: 2.631

9.  Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

Authors:  L W Moreland; M H Schiff; S W Baumgartner; E A Tindall; R M Fleischmann; K J Bulpitt; A L Weaver; E C Keystone; D E Furst; P J Mease; E M Ruderman; D A Horwitz; D G Arkfeld; L Garrison; D J Burge; C M Blosch; M L Lange; N D McDonnell; M E Weinblatt
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

10.  Further development of a physical function scale on a MDHAQ [corrected] for standard care of patients with rheumatic diseases.

Authors:  Theodore Pincus; Tuulikki Sokka; Hannu Kautiainen
Journal:  J Rheumatol       Date:  2005-08       Impact factor: 4.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.